European Society for Radiotherapy and Oncology (ESTRO) 37th Annual Conference
Barcelona International Convention CentreBarcelona, SPAIN Visit the Venue to read more
It is my privilege and great pleasure to invite you to ESTRO 37 that will take place 20-24 April 2018 in Barcelona, Spain.
ESTRO is a society focusing on interdisciplinarity and multidisciplinarity, giving radiation oncologists, medical physicists, radiobiologists, brachytherapists and radiation therapists (RTTs) the opportunity to engage with other oncology organisations with the collective aim of improving cancer treatment.
This conference will convey the theme ‘Innovation for Value and Access’.
Highlighting the fact that Radiation Oncology is an innovative discipline which is rapidly evolving, we remain conscious of the fact that the strive for better and more accurate and precise treatments should go hand in hand with the effort to provide increased equal access to radiation oncology, at both the European and global level, and to a substantial number of patients.
The message we would like to convey with this theme is that innovations in radiation oncology do not only have a positive impact on the value of our treatments, but that we can also use the technological (e.g. automation, efficiency) and radiobiological (e.g. hypofractionation) advances to serve an ever growing subset of patients.
The interdisciplinary component of the scientific programme will include sessions on the following topics:
• Breast and toxicity
• Lung and dose escalation
• How to minimise toxicity in pelvic malignancies in the era of precision radiotherapy
• Immunoradiotherapy: the critical influence of radiation dose, scheduling and dose per fraction
• Oligo metastatic disease, treatment for cure?
• Automatic planning. A blessing or a curse?
• Applying dose-response model across radiation modalities: tumour control and side effects
• Paediatric oncology
• Particle therapy
• New imaging approaches for radiotherapy
• Designing clinical trials in radiotherapy in 2020
• Partial organ treatments to minimise late radiation effects
• Patient involvement, shared decision making, patient-centred care
• Implications of the aging population for radiation oncology
• Challenges in human resources in radiotherapy
• Salvage radiotherapy
• Planning future global radiotherapy services
• Value-based radiotherapy.
The comprehensive scientific programme at ESTRO 37 offers state-of-the-art lectures, symposia, debates on hot topics, as well as a range of educational activities such as pre-meeting courses, contouring workshops, teaching lectures and multidisciplinary tumour boards.
Once again young members have prepared a dedicated Young Scientists Track encompassing relevant lectures and other activities. This will provide a unique opportunity to network and the possibility of becoming involved in, or even starting, international and domestic projects.
The ESTRO annual meetings are successful because of the contribution and quality of the submitted abstracts. The highest scored abstracts form part of the scientific programme in either dedicated sessions or combined with invited talks in a scientific symposium. Other accepted abstracts can be viewed at special stations in the conference centre. You are therefore strongly encouraged to submit an abstract by 23 October 2017 and become part of this prestigious event.
ESTRO 37 houses Europe’s largest industrial exhibition in radiation oncology, an opportunity to interact with industry leaders. Moreover, here you can find the latest developments in technology, techniques and treatment products.
We look forward to welcoming you in enchanting Barcelona.
With warm regards,
ESTRO 37 Chair
Payments can be made by credit card through our secured website. For all questions concerning registration and payments, please contact: firstname.lastname@example.org
No cash registration on site
Please note that payment for desk registrations will have to be made by credit card only. No cash payments will be possible onsite.
Reduced fees apply when the payment is received before specific deadlines:
Early registration rate deadline: 17 January 2018
Late registration rate deadline: 21 March 2018
Desk registration rate: as of 22 March 2018
Please note that in order to benefit from the member price, you must renew your membership for 2018 before registering to the conference. The membership renewal should be done at least 3 days before the early or late deadlines. The membership internal processing and approval process might take up to maximum 3 working days.
The registration fee to the conference includes access to the scientific sessions and exhibition area, coffee breaks, the invitation to the opening ceremony, welcome reception and social evening. The fee does not include lunch. Lunch will be available for purchase in the exhibition area. The fee does not include the programme book as this will be available in electronic format only.
Registration to ESTRO 37 does not give access to the Pre-congress courses and the Contouring workshops. For these separate registrations are required.
Group registrations not allowed
Accompanying persons not allowed
We don’t accept Online Abstracts
Hotel Barcelona Princess,
Avinguda Diagonal, 1,
Barcelona, Catalonia, Spain 08019,
+34 933 56 10 00
Kuoni Congress is the appointed official housing agent for ESTRO 37 and has blocked a variety of hotel rooms at attractive rates. Make sure you secure a room at your preferred hotel as soon as possible as availability is limited. Information on available hotels, rates as well as a convenient hotel map can be found online on the congress website.
Abstract submission deadline 2017-12-20
Abstracts must be submitted on-line on the ESTRO website at: www.estro.org.
We highly recommend completing your submission early - otherwise authors may experience technical delay due to server overload.
For questions regarding the on-line submission process, please e-mail email@example.com.
With the submission of an abstract for ESTRO 37, the first (presenting) author:
Accepts responsibility for the accuracy of the abstract and ascertains that all authors are aware of the content before submission
Accepts to be the contact person for all correspondence related to the abstract and to inform the co- authors about its status
Accepts to identify any financial interest in products or processes described in the abstract. This includes stock ownership, membership on any advisory boards, commercially sponsored research or any other substantial relationships
Certifies that the information to be reported is for exclusive presentation in the session to which the abstract will be assigned if accepted and that the information will not be presented as such at any commercially sponsored satellite symposia during the conference.
Please log in to the abstract submission site with the presenting author login details
Abstracts must be submitted and presented at the conference in English. The Scientific Committee reserves the right to reject an abstract written in poor English
Abstracts will be anonymised before review to ensure fairness and eliminate possible bias. Therefore, it is strictly forbidden to include the authors’ names or institutions in the body of the abstracts.
Track: choose a track keeping in mind that:
Abstracts submitted under the Clinical track are reviewed by clinicians and considered for the clinical track of ESTRO 37
Abstracts submitted under the Physics track are reviewed by physicists and considered for the physics track of ESTRO 37
Abstracts submitted under the Radiobiology track are reviewed by radiobiologists and considered for the radiobiology track of ESTRO 37
Abstracts submitted under the Brachytherapy track are reviewed by brachytherapists and considered for the GEC-ESTRO brachytherapy track of ESTRO 37
Abstracts submitted under the RTT track are reviewed by Radiation TherapisTs (RTTs) and considered for the RTT track only.
It is extremely important that you submit your abstract under the correct track. Submitting under the wrong track will result in your abstract being sent to the wrong experts for review and being scored low as a consequence.
Further advice for submitters:
Delineation abstracts: if the focus of the abstract is on imaging techniques, then the abstract should be submitted under the physics topics; if the focus of the abstract is on correctness of TV, OAR, then the abstract should be submitted under the clinical topics or under the RTT topics
Brachytherapy abstracts: abstracts on combination of BT and EBRT should be submitted under the clinical topics. Abstracts on BT and EBRT may also be submitted under the brachytherapy track topics if the focus of the scientific question is brachytherapy- related, however the submitter should be aware of the fact that the track to which he/she submits may have an influence on the way the abstract is evaluated
Clinical outcome: If there is no clinical outcome (at least toxicity reporting) the abstract should be submitted under the physics topics (or brachytherapy topics).
Topic category: choose the topic category that refers to the main subject of the abstract. The Scientific Committee reserves the right to re-categorise the abstract.
Keywords: authors are required to select a keyword from a pre-defined menu. The list of keywords corresponding to each topic category indicated in the table can be a useful guide to determine the most appropriate topic category under which to submit the abstract. When submitting your abstract only one keyword can be selected from the pre-defined list.
Presentation preference: authors should indicate the presentation preference (oral, poster or no preference). Please note that the final decision on the presentation format rests with the Scientific Committee.
Title: abstract titles should be brief and reflect the content of the abstract. The title (maximum 100 characters) is important since it focuses attention (it is the “showcase” for the presentation). Do not use capital letters in the title except for words that are always capitalised and do not use non-standard abbreviations.
Body of the abstract: abstracts should be structured in such a way as to include (1) Purpose/Objective; (2) Material/methods; (3) Results; (4) Conclusion.
The on-line abstract submission procedure: the on-line abstract submission system will not accept abstracts that exceed 3,000 characters (body of the abstract, including spaces).
The use of standard abbreviations is desirable. A special or unusual abbreviation must be placed (in round brackets) after the first appearance of the word for which it stands.
Table and image: with their submission authors may include maximum two (2) uploads (tables or images) in JPG, PNG or TIFF formats. These uploads are not included in the number of characters. The maximum pixel size of an image is 600(w) x 800 (h) pixel.
Data table: authors may include one data table using the insert table icon (we advise not to copy-paste a table into the body of the abstract). The characters in a data table are included in the overall number of characters allowed.
Equations: can be inserted in the text as images.
ABSTRACT SELECTION PROCESS
Abstracts submitted for presentation will be reviewed by an international panel of experts in the field of the subject.
Abstract review criteria are based on clarity, supporting data, scientific rigour, potential significance, interest in the topic chosen and innovation or usefulness.
Work in progress: abstracts on research obviously not yet performed and results not yet obtained will be banned.
Encore abstracts: papers already presented in another meeting will not be considered, unless the previous audience is distinct from the ESTRO 37 congress audience (e.g. national meetings).
Abstracts will be selected for one of the following presentation formats:
Oral presentation: abstracts selected for oral presentation are presented at one of the proffered paper sessions in the programme.
Poster viewing: abstracts selected for poster viewing sessions will be displayed in a central section of the poster area with posters on a similar topic grouped together. The presenting authors of the posters visit all the posters within each group, along with the audience. By each poster, the presenting author will present the poster in 5 minutes followed by 3 minutes for discussion led by two chairpersons.
Poster: abstracts selected for presentation in (paper) poster format are grouped by topic and are displayed throughout the conference. Only a limited number of abstracts will be selected as posters.
E-poster: abstracts selected as e-posters can be viewed in electronic format in special stations at the conference venue.
Withdrawal of an abstract: abstracts submitted for ESTRO 37 can be withdrawn until 5 December 2017 (to withdraw your abstract you should send an email to firstname.lastname@example.org). After this date, withdrawal of abstracts is no longer possible. Abstracts selected for oral / poster presentation should be presented at the meeting.
In case the first (presenting) author cannot attend the conference, he / she should assign a replacement and inform the ESTRO office of the replacement as soon as possible.
Notification of outcome of abstract submission will be sent by email by end December 2017.
The notification email is sent to the email address of the person whose credentials were used to login to the submission page.
Contact No.: +32 2 775 02 01
Contact No.: +32 2 775 02 01